Rhumbline Advisers Cuts Stock Position in Astera Labs, Inc. $ALAB

Rhumbline Advisers cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 11.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 139,226 shares of the company’s stock after selling 18,658 shares during the quarter. Rhumbline Advisers owned approximately 0.08% of Astera Labs worth $27,260,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in ALAB. Great Valley Advisor Group Inc. increased its holdings in Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after buying an additional 90 shares during the last quarter. Rye Brook Capital LLC grew its position in shares of Astera Labs by 1.1% during the 3rd quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock valued at $1,801,000 after acquiring an additional 100 shares during the period. First Horizon Advisors Inc. increased its stake in shares of Astera Labs by 12.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares during the last quarter. SlateStone Wealth LLC raised its holdings in shares of Astera Labs by 1.3% in the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock worth $2,495,000 after purchasing an additional 160 shares during the period. Finally, Merit Financial Group LLC lifted its stake in Astera Labs by 3.1% in the third quarter. Merit Financial Group LLC now owns 5,683 shares of the company’s stock valued at $1,113,000 after purchasing an additional 170 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. TD Cowen reissued a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Barclays set a $165.00 price target on Astera Labs in a research note on Thursday, January 15th. Citigroup dropped their price objective on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. Roth Mkm increased their target price on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Fourteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $192.89.

Astera Labs Stock Up 2.2%

Shares of ALAB opened at $129.32 on Monday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a market cap of $21.84 billion, a PE ratio of 106.00, a P/E/G ratio of 2.54 and a beta of 1.51. The business’s 50-day moving average price is $164.09 and its 200-day moving average price is $174.83.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the previous year, the company earned $0.37 earnings per share. Astera Labs’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 150,000 shares of the company’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at $261,650,077.64. This represents a 8.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.